Management of patients with pain syndromes associated with COVID-19
The disease caused by the SARS-CoV-2 virus is multi-organ and involves almost all organs and systems. Myalgias and arthralgias and, in particular, back pain are common symptoms of COVID-19 and can be observed both at the onset of the disease and in the postcovid period. The causes of muscle and join...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-10-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1672 |
| _version_ | 1827062747773272064 |
|---|---|
| author | L. T. Akhmedzhanova T. M. Ostroumova O. A. Solokha |
| author_facet | L. T. Akhmedzhanova T. M. Ostroumova O. A. Solokha |
| author_sort | L. T. Akhmedzhanova |
| collection | DOAJ |
| description | The disease caused by the SARS-CoV-2 virus is multi-organ and involves almost all organs and systems. Myalgias and arthralgias and, in particular, back pain are common symptoms of COVID-19 and can be observed both at the onset of the disease and in the postcovid period. The causes of muscle and joint damage include both systemic inflammation and direct viral injury. Traditionally, musculoskeletal pain is treated with non-steroidal anti-inflammatory drugs. However, using this drug class in patients with COVID-19 requires caution due to the presence of comorbid diseases and possible complications of viral infection. The review discusses clinical variants and pathophysiological mechanisms of joints and muscles damage in patients with COVID-19 and treatment tactics for patients with musculoskeletal pain. |
| first_indexed | 2024-04-10T02:01:22Z |
| format | Article |
| id | doaj.art-da68ca95939e44609c5c0156a9418722 |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2025-02-18T20:01:48Z |
| publishDate | 2021-10-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-da68ca95939e44609c5c0156a94187222024-10-17T16:15:29ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422021-10-011359610110.14412/2074-2711-2021-5-96-1011194Management of patients with pain syndromes associated with COVID-19L. T. Akhmedzhanova0T. M. Ostroumova1O. A. Solokha2I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaThe disease caused by the SARS-CoV-2 virus is multi-organ and involves almost all organs and systems. Myalgias and arthralgias and, in particular, back pain are common symptoms of COVID-19 and can be observed both at the onset of the disease and in the postcovid period. The causes of muscle and joint damage include both systemic inflammation and direct viral injury. Traditionally, musculoskeletal pain is treated with non-steroidal anti-inflammatory drugs. However, using this drug class in patients with COVID-19 requires caution due to the presence of comorbid diseases and possible complications of viral infection. The review discusses clinical variants and pathophysiological mechanisms of joints and muscles damage in patients with COVID-19 and treatment tactics for patients with musculoskeletal pain.https://nnp.ima-press.net/nnp/article/view/1672musculoskeletal painmyalgiaarthralgiaosteoarthritissars-cov-2covid-19non-steroidal anti-inflammatory drugsaceclofenac |
| spellingShingle | L. T. Akhmedzhanova T. M. Ostroumova O. A. Solokha Management of patients with pain syndromes associated with COVID-19 Неврология, нейропсихиатрия, психосоматика musculoskeletal pain myalgia arthralgia osteoarthritis sars-cov-2 covid-19 non-steroidal anti-inflammatory drugs aceclofenac |
| title | Management of patients with pain syndromes associated with COVID-19 |
| title_full | Management of patients with pain syndromes associated with COVID-19 |
| title_fullStr | Management of patients with pain syndromes associated with COVID-19 |
| title_full_unstemmed | Management of patients with pain syndromes associated with COVID-19 |
| title_short | Management of patients with pain syndromes associated with COVID-19 |
| title_sort | management of patients with pain syndromes associated with covid 19 |
| topic | musculoskeletal pain myalgia arthralgia osteoarthritis sars-cov-2 covid-19 non-steroidal anti-inflammatory drugs aceclofenac |
| url | https://nnp.ima-press.net/nnp/article/view/1672 |
| work_keys_str_mv | AT ltakhmedzhanova managementofpatientswithpainsyndromesassociatedwithcovid19 AT tmostroumova managementofpatientswithpainsyndromesassociatedwithcovid19 AT oasolokha managementofpatientswithpainsyndromesassociatedwithcovid19 |